GLP Watchdog

Best Oral GLP-1 Tablet & ODT Providers in 2026: Ranked and Reviewed

Injectable vials are what most compounded GLP-1 providers ship. A growing minority also sell oral formulations: oral dissolving tablets (ODT), sublingual tablets, or other non-injectable routes. Be clear about the evidence gap before you switch. Nothing equivalent to the STEP or SURMOUNT randomized trials has been run on oral compounded semaglutide or tirzepatide, so the evidence base is weaker than for the FDA-approved injectables. Two pills hold an FDA approval for weight loss: Novo Nordisk's Wegovy tablets (oral semaglutide) and Lilly's Foundayo (orforglipron), which rests on an entirely different small-molecule chemistry. A needle-averse patient who accepts that weaker evidence base can still make a reasonable choice here. Every provider on the register offering an oral compounded GLP-1, whether alongside injectables or instead of them, is ranked below, with the form factor and the quality of the evidence noted for each.

Lowest verified price: $52/mo143 providers compared

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

143 oral GLP-1 tablet & ODT providers compared · independently scored against our six-factor methodology.

Quick Picks

Starting price per provider. Prices in USD per month; checked November 2026.
#ProviderScore
1EmbodyVisit
2Emerge Weight LossVisit
3LillyDirectVisit
4PreventiveMDVisit
5Rewinding RXVisit

Compare the top providers at a glance

Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.

  • ★ Editor's Pick
    Embody

    a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

    From /mo
    $79
    Coverage
    50 states + DC
    Medications
    SemaglutideTirzepatide
    Visit →
  • Emerge Weight Loss

    cash-pay compounded tirzepatide at a published per-dose price, with no separate doctor or shipping fees

    From /mo
    $149
    Scales with dose
    Coverage
    49 states
    Medications
    Tirzepatide
    Visit →
  • Nationwide Coverage
    LillyDirect

    brand-name Zepbound or Foundayo bought from the manufacturer at a posted cash price

    From /mo
    $149
    Scales with dose
    Coverage
    50 states + DC
    Medications
    OrforglipronTirzepatide
    Visit →
Show 5 more
  • Best Budget
    PreventiveMD

    oral orforglipron alongside the injectables

    From /mo
    $83.25prepaid
    Flat at every dose
    Coverage
    43 states
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
  • Rewinding RX

    compounded semaglutide at one $139 monthly price for any dose, with microdose and drop options

    From /mo
    $119
    Flat at every dose
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • Walgreens Weight Management

    brand-name Wegovy, Zepbound or Foundayo at manufacturer self-pay prices, filled at Walgreens

    From /mo
    $149+ visit fee
    Scales with dose
    Coverage
    48 states + DC
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
  • Ryze Rx

    compounded semaglutide from $119 for the lowest-strength vial, with TRT and peptides on the same account

    From /mo
    $119
    Scales with dose
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • HealthHub

    a low posted price on compounded semaglutide with no subscription to cancel

    From /mo
    $99
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
    Visit →
All 143 providers on this board, in the order this board shows them

The comparison above shows the first 8. This is the full list the filter counts refer to, in the order this board shows them; each name opens that provider’s review.

6weighted dimensions
143oral GLP-1 tablet & ODT providers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →

Brand-name pills are sold too. Novo Nordisk makes two semaglutide tablets: Ozempic tablets for type 2 diabetes and Wegovy tablets for weight. Our guide to Ozempic tablets covers their doses, the empty-stomach rule and what they cost.

Detailed Reviews

1

Embody

Verified partner

Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

9.3

Embody is the brand Modern Metabolic Medicine, Inc. runs through its JoinEm storefront. It sells compounded semaglutide and tirzepatide injections at one price per drug at every dose, $79 and $129 for a one-month supply, plus a compounded oral tirzepatide gum. You pay at checkout, before an OpenLoop Health clinician decides on a prescription, and payments are final.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
10
Support10%
7

Pros

  • ✓Semaglutide costs $79 a month, 60% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $129 a month, 52% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓Serves all 50 states and DC
  • ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to Embody

Cons

  • ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $79/moRead full review →
Visit Embody →
2

Emerge Weight Loss

Best for: cash-pay compounded tirzepatide at a published per-dose price, with no separate doctor or shipping fees

9.1

Emerge Weight Loss sells compounded tirzepatide and little else, at one all-inclusive price per dose with no signup, doctor or shipping fees. Injections start at $224 every 4 weeks and climb by dose to $269 at 10mg. A dissolving tablet version starts at $149 a month. It serves every state except California, takes HSA and FSA cards, and runs intake through a Google Form.

Score Breakdown

Value25%
9.3
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
9.8
Support10%
7

Pros

  • ✓Tirzepatide costs $149 a month, 45% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓Serves 49 states
  • ✓Names 2 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to Emerge Weight Loss

Cons

  • ✗Its tirzepatide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $149/moRead full review →
Visit Emerge Weight Loss →
3

LillyDirect

Best for: brand-name Zepbound or Foundayo bought from the manufacturer at a posted cash price

9.1
Score breakdown, pros and cons

LillyDirect is Eli Lilly's own pharmacy channel for Zepbound (tirzepatide) and the Foundayo (orforglipron) daily tablet. It fills a valid US prescription from any prescriber and can connect you with independent telehealth doctors. Self-pay Zepbound vials and KwikPens cost $299 at 2.5 mg, $399 at 5 mg and $449 at higher doses when you refill within 45 days. Self-pay Foundayo runs $149 to $299 a month by dose. Commercially insured patients with coverage can pay as little as $25 a month.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
10
Support10%
5

Pros

  • ✓Orforglipron costs $149 a month, 40% below the $248 median for brand orforglipron tablets across the sellers we compare
  • ✓Tirzepatide costs $399 a month, 69% below the $1,299 median for brand-name tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓Serves all 50 states and DC
  • ✓Names 2 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to LillyDirect
Starting from $149/moRead full review →
Visit LillyDirect →
4

PreventiveMD

Best for: oral orforglipron alongside the injectables

9.1
Score breakdown, pros and cons

PreventiveMD sells compounded semaglutide and tirzepatide at one price per plan length, whatever the dose, with shipping and provider review included. Month to month, semaglutide is $119 and tirzepatide $139; the advertised $83 and $97 are 12-month plans paid up front. Brand Wegovy, Zepbound and Foundayo carry a $49 monthly membership, with the drug bought from the maker. A US-licensed provider reviews each request in writing within 24 to 48 hours, and it names its four compounding pharmacies.

Score Breakdown

Value25%
9.8
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
8.9
Support10%
7

Pros

  • ✓Semaglutide costs $119 a month, 40% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $139 a month, 48% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Orforglipron costs $149 a month, 40% below the $248 median for brand orforglipron tablets across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price stays the same as your dose goes up
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓Serves 43 states
  • ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to PreventiveMD

Cons

  • ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $83.25/mo, prepaidRead full review →
Visit PreventiveMD →
5

Rewinding RX

Best for: compounded semaglutide at one $139 monthly price for any dose, with microdose and drop options

8.8
Score breakdown, pros and cons

Rewinding RX is a longevity telehealth platform that sells compounded GLP-1s at one monthly price for any dose: $139 for semaglutide and $189 for tirzepatide. Microdose plans run $119 and $169, sublingual drops $139 and $169, and tirzepatide with NAD+ $199. It says it serves all 50 states and that only MDs review cases, though its FAQ says the network also includes nurse practitioners. The pharmacies are not named.

Score Breakdown

Value25%
8.4
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
8.5
Accessibility10%
10
Support10%
7

Pros

  • ✓Semaglutide costs $139 a month, 30% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $169 a month, 37% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price stays the same as your dose goes up
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓Serves all 50 states
  • ✓We found no FDA warning letters issued to Rewinding RX

Cons

  • ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
  • ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $119/moRead full review →
Visit Rewinding RX →

Comparing sellers of oral GLP-1s

Two pills qualify: orforglipron, sold as Foundayo, and oral semaglutide, sold as Ozempic tablets (which replaced Rybelsus in the US) and as the Wegovy pill. Both trade some effectiveness for skipping the needle. What matters is that a prescriber writes for an FDA-approved pill, since the shelves also carry over-the-counter GLP-1 products with no evidence behind them.

What to check

  • A drug rather than a supplement. Orforglipron and oral semaglutide are the oral GLP-1 medications that exist. Anything labeled 'GLP-1 support' and sold without a prescription is not one of them, whatever the packaging implies. Confirm that the prescription product is what ships.
  • The dosing rules differ by pill. Oral semaglutide requires an empty stomach and strict water timing. Orforglipron carries no food restriction. One fits a given routine better than the other, and a seller that never explains the protocol leaves the buyer to find out.
  • How the pill is set against the injection. Injections generally produce more weight loss than pills do. Sellers that say so are describing the evidence. A page presenting its pill as a match for injectables, or an improvement on them, is doing something else.

Red flags

  • Pharmacy unnamed and no LegitScript listing. Two disclosures are checkable on any compounded-GLP-1 seller: the 503A or 503B pharmacy filling the vial, and a LegitScript certification. When a site publishes neither, nothing about the contents of that vial can be confirmed from outside.
  • Instant approval with no clinician you can reach. A prescriber is supposed to read the intake and stay available once dose questions start. Approval issued automatically, with nobody reachable afterward, means the medical layer was removed rather than streamlined.
  • The advertised number is a first month. Headline figures here are usually qualified somewhere. Common forms are an opening rate that steps up with each dose increase, and a membership fee billed separately from the drug itself. Either one can double what leaves your account in month two.
  • B12, MIC, or HCG sold for weight loss. Trial evidence for weight loss sits with the GLP-1 injections and nowhere else on this aisle. A clinic that lists lipotropic, B12, or HCG shots under weight loss is selling past the record, whatever its own site says.

Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.

How we rank, and what counts as “legit”

Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.

Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].

How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].

Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Frequently Asked Questions

Yes, with caveats. Real, trial-backed weight loss comes from the FDA-approved oral GLP-1s: oral semaglutide (Ozempic tablets / Wegovy pill) and orforglipron (Foundayo). Generally less of it than from tirzepatide, the top injectable. Be clear that supplements and 'GLP-1 pills' sold over the counter are not GLP-1 medications at all, and no comparable evidence stands behind them.
Newest and most convenient is orforglipron (Foundayo), a once-daily pill carrying no food-timing rules. Oral semaglutide (oral Wegovy) is FDA-approved too, but it has to go down on an empty stomach, with strict timing around water. A prescription is needed for either, and the providers above write them online.
More weight loss comes from the injections on average, semaglutide and tirzepatide, at the cost of a weekly shot. A pill gives up some of that efficacy in exchange for daily, needle-free convenience, and it can be easier to begin. Where effectiveness is the priority, the injection usually wins. Where avoiding needles or keeping things simple weighs heavier, an oral GLP-1 is legitimate.
Six weighted dimensions produce the score. Value (25%) and Effectiveness (25%) carry the most, then User Experience (15%) and Trust & Safety (15%), then Accessibility (10%) and Support (10%). Behind them sits our research into pricing data, clinical evidence, user reviews and publicly available information. Those weights then combine into one overall score out of 10.
The six-dimension methodology computes each score on its own, and no commercial relationship ever moves a provider's underlying number. Every provider's full score sits on its card for you to check. Some providers do hold affiliate agreements with us, which means a commission reaches us if you click through and buy. On the lists carrying the highest commercial intent — the weight-loss injection and shot lists, the semaglutide and tirzepatide lists, the compounded and cheapest molecule lists, and the fitness-app list — affiliate partners take the top positions. Every other list runs in score order, or in price order on the cheapest lists. That placement is disclosed here, on our methodology page, and on our affiliate-disclosure page.
Sources & methodology — as of November 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Related Rankings